This unique biosensing platform consists of an array of ultrathin graphene...
This unique biosensing platform consists of an array of ultrathin graphene layers and gold nanostructures. The platform, combined with high-tech imaging (Raman spectroscopy), detects genetic material (RNA) and characterizes different kinds of stem cells with greater reliability, selectivity and sensitivity than today’s biosensors.
Source: Letao Yang, KiBum Lee, Jin-Ho Lee and Sy-Tsong (Dean) Chueng

Biosensor may help guide treatment of Alzheimer’s

A Rutgers-led team has created better biosensor technology that may help lead to safe stem cell therapies for treating Alzheimer’s and Parkinson’s diseases and other neurological disorders.

The technology, which features a unique graphene and gold-based platform and high-tech imaging, monitors the fate of stem cells by detecting genetic material (RNA) involved in turning such cells into brain cells (neurons).

Stem cells can become many different types of cells. As a result, stem cell therapy shows promise for regenerative treatment of neurological disorders such as Alzheimer’s, Parkinson’s, stroke and spinal cord injury, with diseased cells needing replacement or repair. But characterizing stem cells and controlling their fate must be resolved before they could be used in treatments. The formation of tumors and uncontrolled transformation of stem cells remain key barriers.

“A critical challenge is ensuring high sensitivity and accuracy in detecting biomarkers – indicators such as modified genes or proteins – within the complex stem cell microenvironment,” said senior author KiBum Lee, a professor in the Department of Chemistry and Chemical Biology in the School of Arts and Sciences at Rutgers University–New Brunswick. “Our technology, which took four years to develop, has demonstrated great potential for analyzing a variety of interactions in stem cells.”

The team’s unique biosensing platform consists of an array of ultrathin graphene layers and gold nanostructures. The platform, combined with high-tech imaging (Raman spectroscopy), detects genes and characterizes different kinds of stem cells with greater reliability, selectivity and sensitivity than today’s biosensors.

The team believes the technology can benefit a range of applications. By developing simple, rapid and accurate sensing platforms, Lee’s group aims to facilitate treatment of neurological disorders through stem cell therapy.

Stem cells may become a renewable source of replacement cells and tissues to treat diseases including macular degeneration, spinal cord injury, stroke, burns, heart disease, diabetes, osteoarthritis and rheumatoid arthritis, according to the National Institutes of Health.

Subscribe to our newsletter

Related articles

Wearable stimulator to zap Alzheimer's disease

Wearable stimulator to zap Alzheimer's disease

Stimulating humans' sense of smell to prevent conditions such as Alzheimer's Disease is the focus of international research.

Chatbot may detect early dementia in time for intervention

Chatbot may detect early dementia in time for intervention

If Alzheimer's dementia is identified early, the decline in neural functioning can be stabilized or even curtailed in some cases.

Understanding the utility of plasmas

Understanding the utility of plasmas

Researchers aim to better explain the way plasmas interact with biological materials to help pave the way for plasma use in wound healing and cancer therapy.

Hydrogel contact lenses for therapeutic use

Hydrogel contact lenses for therapeutic use

Researchers at the Terasaki Institute have developed prototypes of contact lenses that can assist with tear sampling for diagnostic purposes.

A wireless chip shines light on the brain

A wireless chip shines light on the brain

Researchers have developed a chip that is powered wirelessly and can be surgically implanted to read neural signals and stimulate the brain with both light and electrical current.

virtual.COMPAMED receives international resonance

virtual.COMPAMED receives international resonance

COMPAMED 2020 took place entirely online due to the pandemic - but still won over their audiences due to their high degree of international resonance in this format too.

Biosensors open up paths to treatments

Biosensors open up paths to treatments

Self-powered biosensors that could one day lead to wearable devices that do not need to be recharged, or even sensors that are powered by the very bodily process they are designed to monitor.

Supercharged bandages to revolutionise chronic wound treatment

Supercharged bandages to revolutionise chronic wound treatment

Plasma-coated bandages could revolutionise the treatment of chronic wounds such as pressure, diabetic or vascular ulcers that won't heal on their own.

Graphene sensors monitor food safety

Graphene sensors monitor food safety

Researchers are using high-resolution printing technology and the unique properties of graphene to make low-cost biosensors to monitor food safety and livestock health.

Popular articles